Lv11
90 积分 2024-10-29 加入
Cerebral Venous Thrombosis
4小时前
已完结
Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development
19天前
已完结
Low-molecular-weight heparin treatment for portal vein thrombosis in liver cirrhosis: Efficacy and the risk of hemorrhagic complications
28天前
已完结
Anticoagulation in cirrhosis
1个月前
已完结
Atrial fibrillation, liver disease, antithrombotics and risk of cerebrovascular events: A population-based cohort study
1个月前
已完结
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
1个月前
已完结
Atrial fibrillation
1个月前
已完结
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
1个月前
已完结
Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosis
2个月前
已完结
Differential In Vitro Inhibition of Thrombin Generation by Anticoagulant Drugs in Plasma from Patients with Cirrhosis
2个月前
已完结
皖公网安备34019202002308
